Ethic Inc’s Evolent Health EVH Stock Holding History

Ethic Inc’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,025	Closed	-$113K	–	1192
2024 Q4	$113K	Buy	+10,025	New	+$176K	﹤0.01%	1099

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Ethic Inc's EVH Position: Q1 2025 in Review

Ethic Inc sold out of Evolent Health (EVH) in Q1 2025, closing a stake of 10,025 shares — an estimated $113K sold.

Ethic Inc first reported a position in EVH in Q4 2024 and held it in 1 quarter. The position peaked at $113K in Q4 2024. 227 funds tracked by Wall St. Rank hold EVH as of Q1 2025.

Ethic Inc reported no remaining Evolent Health position as of Q1 2025 after selling out during the quarter.
Ethic Inc sold 10,025 Evolent Health shares in Q1 2025, an estimated $113K.
Ethic Inc first reported a position in Evolent Health in Q4 2024 and held it in 1 quarter.
Ethic Inc's Evolent Health position peaked at $113K in Q4 2024.
227 funds tracked by Wall St. Rank held Evolent Health as of Q1 2025.

Based on Ethic Inc's 13F filing for Q1 2025, filed 13 May 2025.